Skip to main content Back to Top
Advertisement

2/12/2020

Epinephrine Auto-Injectors

Products Affected - Description

    • Epinephrine injection, Amneal, 0.15 mg/0.15 mL, auto-injector, 2 count, NDC 00115-1695-49
    • Epinephrine injection, Amneal, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00115-1694-49

Reason for the Shortage

    • Amneal has discontinued Adrenaclick. Amneal acquired Impax in 2018.
    • Mylan has epinephrine auto-injectors available.
    • Sandoz launched Symjepi in January 2019 and product is available.
    • Teva has epinephrine auto-injectors available.

Available Products

    • Auvi-Q injection, Kaleo, 0.1 mg/0.1 mL, auto-injector, 2 count, NDC 60842-0021-01
    • Auvi-Q injection, Kaleo, 0.15 mg/0.15 mL, auto-injector, 2 count, NDC 60842-0022-01
    • Auvi-Q injection, Kaleo, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 60842-0023-01
    • EpiPen injection, Mylan, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0500-02
    • EpiPen Jr injection, Mylan, 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0501-02
    • Symjepi injection, Sandoz, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00781-3442-20
    • Epinephrine injection, Mylan, 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0101-02
    • Epinephrine injection, Mylan, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 49502-0102-02
    • Epinephrine injection, Teva, 0.15 mg/0.3 mL, auto-injector, 2 count, NDC 00093-5985-27
    • Epinephrine injection, Teva, 0.3 mg/0.3 mL, auto-injector, 2 count, NDC 00093-5986-27

Estimated Resupply Dates

    • Amneal has epinephrine 0.15 mg/0.15 mL and 0.3 mg/0.3 mL auto-injectors on allocation.

Safety

    • FDA has extended the expiration dating for certain lots of EpiPen and some generic epinephrine auto-injectors. https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm563360.htm

Updated

Updated February 12, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 3, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins